A recent study revealed that high GBP2 is associated with better prognosis in breast cancer, particularly in quickly proliferating tumors.12 Further testing predicted that GBP2 correlates with T-cell signature, indicating tumor infiltration with T cells. The gene discussed is GBP2; the disease is neoplasm.